Heartbeam (BEAT) Stock: Buy, Sell, or Hold?
BEAT - Heartbeam, Inc. Common Stock
$0.37
0.00 (-0.48%)
▼
5d:
-14.41%
30d:
-20.5%
90d:
-50.51%
WAIT
LOW Confidence
Analysis Updated: Sep 28, 2026 12:00 AM ET
Earnings: Nov 12, 2026
Get Alerted When BEAT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BEAT is down 14.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BEAT is down 14.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BEAT is currently trading at $0.37, which is considered oversold relative to its 30-day fair value range of $0.40 to $0.48.
Technical Outlook: Technically, BEAT is in a strong downtrend. Immediate support is located at $0.35, while resistance sits at $0.45.
Market Sentiment: BEAT scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.50 (+838.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BEAT is in a strong downtrend. Immediate support is located at $0.35, while resistance sits at $0.45.
Market Sentiment: BEAT scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.50 (+838.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.40 -
$0.48
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 838.3% below Wall St target ($3.50)
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.40 -
$0.48
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.36
Resistance Level
$0.45
Current Trend
Strong Downtrend
Technical data as of
Sep 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.30
Wall Street Target
$3.50
(+838.3%)
Share & Embed Analysis
Last updated: September 29, 2026 9:54 AM ET
Data refreshes hourly during market hours. Next update: 10:54 AM
Data refreshes hourly during market hours. Next update: 10:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BEAT showing a specific setup today?
Insider Activity (6 Months)
7
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Branislav Vajdic
BUY
31250 shares
2026-04-16
Marga Ortigas-Wedekind
BUY
25000 shares
2026-04-16
Mark E Strome
BUY
750000 shares
2026-04-16
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$297 | 43 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 56 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 76 BUY |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 68 BUY |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 55 HOLD |
